Analyst firms · Morgan Stanley · OGN
Morgan Stanley OGN price target and rating history
Organon & Co. (OGN) · Health Care
Morgan Stanley rates Organon & Co. (OGN) Equal-Weight with a $35 price target, as of its latest action on Apr 6, 2022. It has published 3 rating actions on OGN since August 2021, including 0 upgrades and 0 downgrades.
- Current rating
- Equal-Weight
- Price target
- $35
- Median target, all firms
- Too few
- Actions on OGN
- 3
Morgan Stanley price target on OGN
Every Morgan Stanley rating on OGN
- Apr 6, 2022
- Feb 22, 2022
- Aug 16, 2021
How other firms rate OGN
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Piper Sandler | Neutral | $14 | Apr 28, 2026 |
| Barclays | Underweight | $7.50 | Dec 9, 2025 |
Questions about Morgan Stanley and OGN
- What is Morgan Stanley's price target for OGN?
- Morgan Stanley's latest stated price target for Organon & Co. (OGN) is $35, from its action on Apr 6, 2022.
- What is Morgan Stanley's rating on OGN?
- Morgan Stanley rates OGN Equal-Weight, a neutral rating, as of Apr 6, 2022.
- When did Morgan Stanley last change its view on OGN?
- On Apr 6, 2022, Morgan Stanley resumes coverage at Equal-Weight, price target $35.
More OGN rating histories
All Morgan Stanley ratingsOGN news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.